Royal Bank of Canada’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-29,645
Closed -$13K – 7173
2015
Q3
$13K Buy
29,645
+3,883
+15% +$2.22K ﹤0.01% 5790
2015
Q2
$13K Sell
25,762
-13,041
-34% -$8.86K ﹤0.01% 5962
2015
Q1
$28K Buy
38,803
+8,237
+27% +$5.29K ﹤0.01% 5218
2014
Q4
$16K Buy
30,566
+2,791
+10% +$1.69K ﹤0.01% 5475
2014
Q3
$16K Buy
27,775
+10,433
+60% +$13.2K ﹤0.01% 5357
2014
Q2
$23K Buy
17,342
+526
+3% +$754 ﹤0.01% 5159
2014
Q1
$30K Buy
16,816
+3,979
+31% +$6.72K ﹤0.01% 5059
2013
Q4
$19K Sell
12,837
-48,944
-79% -$110K ﹤0.01% 5284
2013
Q3
$150K Buy
61,781
+51,101
+478% +$141K ﹤0.01% 4254
2013
Q2
$30K Buy
+10,680
New +$29.5K ﹤0.01% 4893

Other funds holding ONCY

Royal Bank of Canada's ONCY Position: Q4 2015 in Review

Royal Bank of Canada sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 29,645 shares — an estimated $13K sold.

Royal Bank of Canada first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $150K in Q3 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Royal Bank of Canada reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 29,645 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $13K.
  • Royal Bank of Canada first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
  • Royal Bank of Canada's ONCOLYTICS BIOTECH INC position peaked at $150K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.